The proposed 2027 Home Health Prospective Payment System rule suggests health agencies may receive an estimated 2.4% payment increase—approximately $420 million—while Medicare beneficiaries would continue to receive expanded access to care at home.

What makes CRUSH particularly interesting is the breadth of who and what it could impact. This isn't just about DME fraud. The ideas CMS is considering potentially touch hospitals, laboratories, Medicare Advantage and Part D plans, Medicaid and CHIP, DMEPOS suppliers, provider enrollment, billing, AI, payment suspensions, ownership disclosure, beneficiary solicitation and more.

At first glance, the proposed 2027 Home Health Prospective Payment System rule appears to be a routine update. But buried within the proposed rule is something far more significant. Read more to understand the compliance implications.

CMS’s 2026 Final Rule brings big changes to Medicare Advantage and Part D—including stronger inpatient review rules, codified cost-sharing caps, expanded appeals rights, and tighter audit protocols. Compliance is no longer optional—these updates are now mandatory. Read on for key takeaways and practical steps your team can take to prepare.